Brain structure and function as mediators of the effects of amyloid on memory
- PMID: 25681451
- PMCID: PMC4371407
- DOI: 10.1212/WNL.0000000000001375
Brain structure and function as mediators of the effects of amyloid on memory
Abstract
Objective: The objective of this study was to test whether effects of β-amyloid (Aβ) pathology on episodic memory were mediated by metabolism and gray matter volume in the early stages of Alzheimer disease.
Methods: This was a prospective cohort study. We measured baseline Aβ (using florbetapir-PET), brain function (using fluorodeoxyglucose-PET), and brain structure (using MRI). A mediation analysis was performed to test whether statistical effects of Aβ positivity on cross-sectional and longitudinal episodic memory were mediated by hypometabolism or regional gray matter volume in cognitively healthy controls (CN, n = 280) and mild cognitive impairment (MCI, n = 463).
Results: Lower memory scores were associated with Aβ positivity (CN, mildly; MCI, strongly), smaller gray matter volumes (CN, few regions, including hippocampus; MCI, widespread), and hypometabolism. Smaller volumes and hypometabolism mediated effects of Aβ in MCI but not in CN. The strongest individual regions mediated up to approximately 25%. A combination of brain structure and function mediated up to approximately 40%. In several regions, gray matter atrophy and hypometabolism predicted episodic memory without being associated (at p < 0.05) with Aβ positivity.
Conclusions: Changes in brain structure and function appear to be, in part, downstream events from Aβ pathology, ultimately resulting in episodic memory deficits. However, Aβ pathology is also strongly related to memory deficits through mechanisms that are not quantified by these imaging measurements, and episodic memory decline is partly caused by Alzheimer disease-like brain changes independently of Aβ pathology.
© 2015 American Academy of Neurology.
Figures



Similar articles
-
Cross-sectional and longitudinal analysis of the relationship between Aβ deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease.JAMA Neurol. 2013 Jul;70(7):903-11. doi: 10.1001/jamaneurol.2013.1062. JAMA Neurol. 2013. PMID: 23712469
-
Cognitive consequences of high Aβ amyloid in mild cognitive impairment and healthy older adults: implications for early detection of Alzheimer's disease.Neuropsychology. 2013 May;27(3):322-332. doi: 10.1037/a0032321. Neuropsychology. 2013. PMID: 23688214
-
Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology.JAMA Neurol. 2017 Jun 1;74(6):650-659. doi: 10.1001/jamaneurol.2016.5349. JAMA Neurol. 2017. PMID: 28319241 Free PMC article.
-
Long night's journey into the day: amyloid-β imaging in Alzheimer's disease.J Alzheimers Dis. 2013;33 Suppl 1:S349-59. doi: 10.3233/JAD-2012-129034. J Alzheimers Dis. 2013. PMID: 22710919 Review.
-
Amyloid-β and cognition in aging and Alzheimer's disease: molecular and neurophysiological mechanisms.J Alzheimers Dis. 2013;33 Suppl 1:S79-86. doi: 10.3233/JAD-2012-129003. J Alzheimers Dis. 2013. PMID: 22531423 Review.
Cited by
-
Joint associations of β-amyloidosis and cortical thickness with cognition.Neurobiol Aging. 2018 May;65:121-131. doi: 10.1016/j.neurobiolaging.2018.01.017. Epub 2018 Feb 2. Neurobiol Aging. 2018. PMID: 29471214 Free PMC article.
-
Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials.Alzheimers Dement. 2017 Apr;13(4):e1-e85. doi: 10.1016/j.jalz.2016.11.007. Epub 2017 Mar 22. Alzheimers Dement. 2017. PMID: 28342697 Free PMC article. Review.
-
Can hippocampal subfield measures supply information that could be used to improve the diagnosis of Alzheimer's disease?PLoS One. 2022 Nov 3;17(11):e0275233. doi: 10.1371/journal.pone.0275233. eCollection 2022. PLoS One. 2022. PMID: 36327265 Free PMC article.
-
Mild Cognitive Impairment Staging Yields Genetic Susceptibility, Biomarker, and Neuroimaging Differences.Front Aging Neurosci. 2020 Jun 5;12:139. doi: 10.3389/fnagi.2020.00139. eCollection 2020. Front Aging Neurosci. 2020. PMID: 32581762 Free PMC article.
-
Dynamic association between AT(N) profile and cognition mediated by cortical thickness in Alzheimer's continuum.Neuroimage Clin. 2020;27:102282. doi: 10.1016/j.nicl.2020.102282. Epub 2020 May 26. Neuroimage Clin. 2020. PMID: 32590333 Free PMC article.
References
-
- Joshi AD, Pontecorvo MJ, Clark CM, et al. Performance characteristics of amyloid PET with florbetapir F 18 in patients with Alzheimer's disease and cognitively normal subjects. J Nucl Med 2012;53:378–384. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources